Blindness Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Blindness stocks.

Recent Signals

Date Stock Signal Type
2021-07-29 ALC Upper Bollinger Band Walk Strength
2021-07-29 ALC Stochastic Reached Overbought Strength
2021-07-29 ALIM 20 DMA Resistance Bearish
2021-07-29 ALIM Bollinger Band Squeeze Range Contraction
2021-07-29 ALIM Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-07-29 EYES Bollinger Band Squeeze Range Contraction
2021-07-29 EYES NR7 Range Contraction
2021-07-29 EYES Narrow Range Bar Range Contraction
2021-07-29 EYES Calm After Storm Range Contraction
2021-07-29 FGEN New 52 Week Closing Low Bearish
2021-07-29 FGEN Narrow Range Bar Range Contraction
2021-07-29 GRAY Bollinger Band Squeeze Range Contraction
2021-07-29 GRAY NR7 Range Contraction
2021-07-29 GRAY Narrow Range Bar Range Contraction
2021-07-29 ISEE Fell Below 20 DMA Bearish
2021-07-29 OCGN NR7 Range Contraction
2021-07-29 OCGN Narrow Range Bar Range Contraction
2021-07-29 OCGN Bollinger Band Squeeze Range Contraction
2021-07-29 OCGN 20 DMA Resistance Bearish
2021-07-29 OCUP NR7 Range Contraction
2021-07-29 OCUP Narrow Range Bar Range Contraction
2021-07-29 OCUP 20 DMA Support Bullish
2021-07-29 OCUP Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-07-29 OPT 20 DMA Support Bullish
2021-07-29 OPT Bollinger Band Squeeze Range Contraction

Blindness Stocks Recent News

Date Stock Title
Jul 29 OCGN The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OCGN, HMPT and YMM
Jul 29 OCGN CLASS ACTION UPDATE for OCGN, BLCT and OTLY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Jul 29 OCGN ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ocugen, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action – OCGN
Jul 29 FGEN FibroGen to Report Second Quarter 2021 Financial Results
Jul 29 FGEN What's Next for FibroGen After an FDA Vote Against Its Anemia Drug?
Jul 29 OCGN LAWSUITS FILED AGAINST OCGN, BLCT and PLL - Jakubowitz Law Pursues Shareholders Claims
Jul 29 OCGN Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, CarLotz, and RenovaCare and Encourages Investors to Contact the Firm
Jul 28 OCGN SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ocugen, Inc. of Class Action Lawsuit and Upcoming Deadline - OCGN
Jul 28 ALIM Alimera Sciences (ALIM) Earnings Expected to Grow: Should You Buy?
Jul 28 OCGN The Gross Law Firm Announces Class Actions on Behalf of Shareholders of OCGN, ATHA and RKT
Jul 28 OCGN CLASS ACTION UPDATE for OCGN, HMPT and BLCT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Jul 28 OCGN OCGN, TEDU & HMPT Class Action Reminders and Upcoming Deadlines: Bronstein, Gewirtz & Grossman LLC
Jul 28 OCGN SHAREHOLDER ALERT: OCGN BZ OTLY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Jul 28 OCGN OCGN ALERT: Robbins Geller Rudman & Dowd LLP Announces Opportunity for Investors with Substantial Losses to Lead the Ocugen, Inc. Class Action Lawsuit
Jul 28 ISEE Iveric Bio to Report Second Quarter 2021 Financial Results and Host Conference Call on Wednesday, August 4, 2021
Jul 28 FGEN The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Jul 28 GKOS Glaukos Corporation (GKOS): Are Hedge Funds Right About This Stock?
Jul 27 OCGN LAWSUITS FILED AGAINST OCGN, HMPT and COIN - Jakubowitz Law Pursues Shareholders Claims
Jul 27 OCGN DEADLINE ALERT for OCGN, TEDU, ATHA, REKR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Jul 27 OCGN The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SPCE, OCGN and CRMD

Visual impairment, also known as vision impairment or vision loss, is a decreased ability to see to a degree that causes problems not fixable by usual means, such as glasses. Some also include those who have a decreased ability to see because they do not have access to glasses or contact lenses. Visual impairment is often defined as a best corrected visual acuity of worse than either 20/40 or 20/60. The term blindness is used for complete or nearly complete vision loss. Visual impairment may cause people difficulties with normal daily activities such as driving, reading, socializing, and walking.The most common causes of visual impairment globally are uncorrected refractive errors (43%), cataracts (33%), and glaucoma (2%). Refractive errors include near sighted, far sighted, presbyopia, and astigmatism. Cataracts are the most common cause of blindness. Other disorders that may cause visual problems include age related macular degeneration, diabetic retinopathy, corneal clouding, childhood blindness, and a number of infections. Visual impairment can also be caused by problems in the brain due to stroke, premature birth, or trauma among others. These cases are known as cortical visual impairment. Screening for vision problems in children may improve future vision and educational achievement. Screening adults without symptoms is of uncertain benefit. Diagnosis is by an eye exam.The World Health Organization (WHO) estimates that 80% of visual impairment is either preventable or curable with treatment. This includes cataracts, the infections river blindness and trachoma, glaucoma, diabetic retinopathy, uncorrected refractive errors, and some cases of childhood blindness. Many people with significant visual impairment benefit from vision rehabilitation, changes in their environment, and assistive devices.As of 2015 there were 940 million people with some degree of vision loss. 246 million had low vision and 39 million were blind. The majority of people with poor vision are in the developing world and are over the age of 50 years. Rates of visual impairment have decreased since the 1990s. Visual impairments have considerable economic costs both directly due to the cost of treatment and indirectly due to decreased ability to work.

More about Blindness
Browse All Tags